Historical Stock Price
KITE historical stock prices picture
KITE (KITE) has the following price history information. Looking back at KITE historical stock prices for the last five trading days, on October 13, 2017, KITE opened at $179.79, traded as high as $179.79 and as low as $179.79, and closed at $179.79. Trading volume was a total of 0 shares. On October 16, 2017, KITE opened at $179.79, traded as high as $179.79 and as low as $179.79, and closed at $179.79. Trading volume was a total of 0 shares. On October 17, 2017, KITE opened at $179.79, traded as high as $179.79 and as low as $179.79, and closed at $179.79. Trading volume was a total of 0 shares. On October 18, 2017, KITE opened at $179.79, traded as high as $179.79 and as low as $179.79, and closed at $179.79. Trading volume was a total of 0 shares. On October 19, 2017, KITE opened at $179.79, traded as high as $179.79 and as low as $179.79, and closed at $179.79. Trading volume was a total of 0 shares.

KITE Historical Stock Prices By Date:

KITE historical cagr picture

Below, we examine the compound annual growth rate — CAGR for short — of an investment into KITE shares, starting with a $10,000 purchase of KITE, and working forward through the historical stock price information to today.

Growth of $10,000.00
Without Dividends Reinvested

Start date: 06/23/2014
End date: 10/19/2017
Start price/share: $30.53
End price/share: $179.79
Dividends collected/share: $0.00
Total return: 488.90%
Average Annual Total Return: 70.42%
Starting investment: $10,000.00
Ending investment: $58,890.29
Years: 3.33
Date Open High Low Close Volume
10/13/2017 $179.79 $179.79 $179.79 $179.79 0
10/16/2017 $179.79 $179.79 $179.79 $179.79 0
10/17/2017 $179.79 $179.79 $179.79 $179.79 0
10/18/2017 $179.79 $179.79 $179.79 $179.79 0
10/19/2017 $179.79 $179.79 $179.79 $179.79 0
Kite Pharma is a clinical-stage biopharmaceutical company focused on the development and commercialization of cancer immunotherapy products designed to target and kill cancer cells. Co. uses its engineered autologous cell therapy for the treatment of cancer. Co.'s therapy involves modifying a patient's T cells outside the patient's body (ex vivo) causing the T cells to express chimeric antigen receptors (CARs) or T cell receptors and then reinfusing the engineered T cells back into the patient. Co.'s primary product candidate, KTE-C19, is a CAR-based therapy that targets the CD19 antigen, a protein expressed on the cell surface of B-cell lymphomas and leukemias.
Date Close
10/13/2017$179.79
10/16/2017$179.79
10/17/2017$179.79
10/18/2017$179.79
10/19/2017$179.79
KITE is categorized under the Healthcare sector; below are some other companies in the same sector:

KMPH Historical Stock Prices
KND Historical Stock Prices
KOOL Historical Stock Prices
KPTI Historical Stock Prices
KRYS Historical Stock Prices
KTWO Historical Stock Prices
KURA Historical Stock Prices
KYTH Historical Stock Prices
LBIO Historical Stock Prices
LBMH Historical Stock Prices

Email EnvelopeFree KITE Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts


KITE Historical Stock Prices | www.HistoricalStockPrice.com | Copyright © 2013 - 2024, All Rights Reserved

Nothing in www.HistoricalStockPrice.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 9.5%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 9.5%.